General MedicationsINTRAVENOUSStandard

EPHEDRINE SULFATE

Standard Dose

25MG/5ML (5MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview EPHEDRINE SULFATE is listed in Drugs@FDA under application 218271 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient EPHEDRINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 25MG/5ML (5MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-03-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPHEDRINE SULFATE is listed in Drugs@FDA under application 218271 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPHEDRINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 25MG/5ML (5MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-03-11 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.